Form 8-K - Current report:
SEC Accession No. 0001193125-23-147643
Filing Date
2023-05-18
Accepted
2023-05-18 08:01:29
Documents
12
Period of Report
2023-05-17
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d469375d8k.htm   iXBRL 8-K 30443
  Complete submission text file 0001193125-23-147643.txt   151469

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA hznp-20230517.xsd EX-101.SCH 2886
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20230517_lab.xml EX-101.LAB 17167
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20230517_pre.xml EX-101.PRE 10812
6 EXTRACTED XBRL INSTANCE DOCUMENT d469375d8k_htm.xml XML 3296
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35238 | Film No.: 23933745
SIC: 2834 Pharmaceutical Preparations